No. Tempus tests can only be ordered by your physician. If you’d like to advocate for your own Tempus testing, please email patients@tempus.com for documents and information you can share with your physician.

Knowing the alterations that are driving your cancer help identify targeted FDA-approved therapies and clinical trials that may be more effective treatment options for you. 

Your doctor will need to order the test directly from Tempus by completing a simple requisition form. We will coordinate the collection of specimen samples (blood or saliva, as necessary) and will request a tumor sample from your hospital’s pathology department, when relevant.

We will work with your hospitalʼs pathology department to obtain your tissue sample. Your tumor sample will be sent to our secure molecular sequencing lab.

Your physician will receive our comprehensive report that contains information regarding your tumor biology, potential targeted therapies, and your medical history. The report will highlight recruiting clinical trial options, if available, that fit your profile. We also provide other biologically relevant insights for deeper exploration of available therapeutic options.

From the time Tempus receives the necessary specimen samples, it typically takes approximately two weeks to sequence and generate your patient report. Your physician will contact you when the results are ready.

The report will be sent to your physician, and he or she will discuss the results with you.

Tempus accepts all insurance plans. We will work with your insurance company to submit for reimbursement. If coverage is denied, Tempus will file an appeal(s) on your behalf.

Yes. Tempus offers a comprehensive patient assistance program. Through our program, eligible patients may reduce their total financial responsibility to anywhere between $0-$100. Apply for assistance at access.tempus.com.

Our services explore options for all patients, including those with metastatic, refractory and recurrent cancer; cancer of unknown origin; rare or uncommon solid tumors with limited treatment options; or solid tumors not responding to standard of care. It’s up to your doctor to decide if genomic testing can help in your cancer treatment.

Our comprehensive approach structures your clinical data and tests hundreds of cancer related genes to better understand your unique disease and optimize treatment options. By testing both your tumor tissue DNA and your normal tissue DNA, as well as your tumor tissue RNA, we improve the detection of tumor-specific alterations, which allows us to provide deeper insights about your tumor’s biology and match potential therapy options that may be effective in treating your unique cancer type.